GlassScriptPhysician profile
Emily M Scavella
NPI 1124278304
$12,907.13
in general payments reported to CMS, 2019-2025
48 companies · $2,638 in 2025
The $2,638 reported for 2025 was more than what 94% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,118 · 2022: $3,481 · 2023: $2,934 · 2024: $2,736 · 2025: $2,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,304 · Education: $4.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,304.07 |
| Education | $4.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,401.57 | 2021-2025 | Wegovy, Ozempic, Sogroya |
| Lilly USA, LLC | $1,356.52 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Dexcom, INC. | $1,353.81 | 2022-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $582.10 | 2021-2024 | Farxiga, Lokelma |
| Abbvie INC. | $580.78 | 2021-2025 | |
| Tandem Diabetes Care, INC. | $549.97 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbott Laboratories | $483.13 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Amneal Pharmaceuticals LLC | $444.08 | 2021-2025 | Unithroid |
| Amgen INC. | $421.88 | 2021-2025 | Evenity, Prolia, Tepezza |
| Bayer Healthcare Pharmaceuticals INC. | $390.46 | 2021-2025 | |
| Antares Pharma, INC. | $372.34 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Insulet Corporation | $344.87 | 2021-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $331.50 | 2022-2024 | |
| Corcept Therapeutics | $326.13 | 2022-2025 | Korlym |
| Cequr Corporation | $313.65 | 2022-2025 | Cequr Simplicity |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $284.15 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $223.44 | 2021-2023 | Steglatro |
| Azurity Pharmaceuticals, INC. | $190.40 | 2023-2024 | Triptodur, Triptodur |
| Madrigal Pharmaceuticals | $188.63 | 2025 | Rezdiffra |
| Astellas Pharma US INC | $146.16 | 2023-2025 | Veozah |
| Amarin Pharma, INC. | $142.99 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.85 | 2021-2025 | Jardiance, Synjardy |
| Kyowa Kirin, INC. | $124.67 | 2024-2025 | Crysvita |
| Neurocrine Biosciences, INC. | $97.00 | 2024-2025 | |
| Ascendis Pharma Endocrinology INC | $94.86 | 2022-2025 | Skytrofa |
| Recordati_rare_diseases_inc. | $93.14 | 2022-2025 | Isturisa, Signifor Lar |
| Medtronic, INC. | $92.09 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Pfizer INC. | $76.28 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $73.83 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $72.76 | 2022-2025 | |
| Radius Health, INC. | $64.04 | 2021-2022 | |
| Beta Bionics, INC. | $61.82 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Verity Pharmaceuticals INC. | $54.19 | 2024-2025 | Tlando |
| Tolmar, INC. | $48.08 | 2023-2025 | Fensolvi |
| Glaxosmithkline, LLC. | $46.47 | 2023 | Arexvy, Shingrix |
| Alexion Pharmaceuticals, INC. | $44.65 | 2024 | Strensiq |
| Amryt Pharma Holdings LTD | $35.89 | 2022-2023 | Mycapssa |
| Tolmar Pharmaceuticals, INC. | $34.33 | 2021-2022 | |
| Chiesi USA, INC. | $29.78 | 2024-2025 | Mycapssa |
| Smith+Nephew, INC. | $28.61 | 2024 | Grafix Pl |
| Horizon Therapeutics Plc | $27.73 | 2023 | Tepezza |
| Ibsa Pharma INC. | $27.61 | 2021-2022 | |
| Eusa Pharma (US) LLC | $26.25 | 2022 | |
| Alvogen INC | $23.96 | 2025 | Teriparatide |
| Ipsen Biopharmaceuticals, INC | $22.68 | 2022 | |
| Acella Pharmaceuticals, LLC | $16.51 | 2025 | NP Thyroid 60 |
| Sandoz INC. | $16.23 | 2025 | Omnitrope |
| Zealand Pharma US, INC. | $15.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Scavella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.